BAYESIAN BIVARIATE META-ANALYSIS OF DIAGNOSTIC TEST ACCURACY: JOINT MODELING OF SENSITIVITY AND SPECIFICITY
Author(s)
Parampal Bajaj, MSc1, Akanksha Sharma, MSc1, Kushagra Pandey, MA1, Rashi Rani, MSc1, Shubhram Pandey, MSc2.
1Heorlytics Pvt. Ltd, Mohali, India, 2Pharmacoevidence Pvt. Ltd., SAS Nagar, Mohali, India.
1Heorlytics Pvt. Ltd, Mohali, India, 2Pharmacoevidence Pvt. Ltd., SAS Nagar, Mohali, India.
OBJECTIVES: Meta-analysis of diagnostic test accuracy requires specialized methods to jointly synthesize sensitivity and specificity while accounting for theircorrelation across studies. Bayesian approaches offer a flexible framework for combining evidence and quantifying uncertainty. This study aimed to conduct aBayesian bivariate meta-analysis of diagnostic accuracy using study-level sensitivity and specificity estimates derived under a common diagnostic threshold.
METHODS: Hypothetical diagnostic accuracy data were generated for ten studies, including counts of true positives, false positives, false negatives, and truenegatives. A Bayesian bivariate random-effects model was implemented in WinBUGS via R (R2WinBUGS package; version 4.5.0), following NICE TechnicalSupport Document 25 guidance. Between-study heterogeneity was modeled using vague priors (mean 0, variance 2). Posterior inference was performed usingMarkov Chain Monte Carlo simulation with 2,000 burn-in iterations and 80,000 sampling iterations across three chains.
RESULTS: The pooled posterior median sensitivity was 0.95 (95% credible interval [CrI]: 0.91-0.97), while the pooled specificity was 0.67 (95% CrI: 0.48-0.82). Theestimated between-study correlation between sensitivity and false-positive fraction was 0.41 (95% CrI: −0.40 to 0.89), indicating moderate correlation andsupporting joint modelling of diagnostic accuracy measures.
CONCLUSIONS: Bayesian bivariate random-effects models provide a robust framework for meta-analysis of diagnostic accuracy by jointly estimating sensitivity and specificity and appropriately capturing between-study correlation and uncertainty. This approach enhances interpretability and supports evidence synthesis for diagnostic decision making.
METHODS: Hypothetical diagnostic accuracy data were generated for ten studies, including counts of true positives, false positives, false negatives, and truenegatives. A Bayesian bivariate random-effects model was implemented in WinBUGS via R (R2WinBUGS package; version 4.5.0), following NICE TechnicalSupport Document 25 guidance. Between-study heterogeneity was modeled using vague priors (mean 0, variance 2). Posterior inference was performed usingMarkov Chain Monte Carlo simulation with 2,000 burn-in iterations and 80,000 sampling iterations across three chains.
RESULTS: The pooled posterior median sensitivity was 0.95 (95% credible interval [CrI]: 0.91-0.97), while the pooled specificity was 0.67 (95% CrI: 0.48-0.82). Theestimated between-study correlation between sensitivity and false-positive fraction was 0.41 (95% CrI: −0.40 to 0.89), indicating moderate correlation andsupporting joint modelling of diagnostic accuracy measures.
CONCLUSIONS: Bayesian bivariate random-effects models provide a robust framework for meta-analysis of diagnostic accuracy by jointly estimating sensitivity and specificity and appropriately capturing between-study correlation and uncertainty. This approach enhances interpretability and supports evidence synthesis for diagnostic decision making.
Conference/Value in Health Info
2026-09, ISPOR Asia Pacific 2026, Bangkok, Thailand
Value in Health, Volume 55, Issue S1
Code
MSR18
Topic
Methodological & Statistical Research
Disease
No Additional Disease & Conditions/Specialized Treatment Areas